Overview

Intermountain Healthcare's Enhanced Recovery Protocol for Colon Surgery With and Without Alvimopan Use

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of alvimopan to our care process model for colon resection patients will decrease length of stay. The care process model is a combination of optimal IV fluid management, early feeding, early ambulation, patient education, and pain management.
Phase:
N/A
Details
Lead Sponsor:
Intermountain Health Care, Inc.
Collaborator:
Cubist Pharmaceuticals LLC
Treatments:
Alvimopan